
Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments
This podcast episode reviews recent advances in the treatment of IDH1-mutant acute myeloid leukemia (AML), focusing on the mechanisms, efficacy, and safety profiles of approved IDH1 inhibitors. The purpose is to present






